MetaCap

Who Owns Quantum Biopharma Stock?

NASDAQ: QNTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.94-0.17 (-5.47%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
12.00%
Institutional holders
28
  • Institutions 12.0%
  • Insiders 8.4%
  • Public and other 79.6%

Who owns Quantum Biopharma stock?

Institutional investors own about 12.0% of Quantum Biopharma's shares, spread across 28 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 8.40% of QNTM.

The largest institutional holders are AdvisorShares Investments, LLC (5.33%), Jane Street Group, LLC (1.27%) and Platform Technology Partners (1.08%). Together, the top 10 institutions control 10.7% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their QNTM positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of QNTM

Quantum Biopharma top institutional holders
InstitutionShares% HeldChange
AdvisorShares Investments, LLC203.56K5.33%+87.5%
Jane Street Group, LLC48.35K1.27%+53.5%
Platform Technology Partners41.12K1.08%0.0%
UBS Group AG33.41K0.88%+361.6%
Steward Partners Investment Advisory, LLC27.88K0.73%+536.4%
Citadel Advisors Llc15.86K0.42%0.0%
Marex Group Ltd.13.44K0.35%-0.2%
Mariner, LLC10.00K0.26%-0.6%
Lanark Financial Inc7.00K0.18%+100.0%
Osaic Holdings Inc.6.29K0.16%-1.3%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of QNTM

Quantum Biopharma top fund holders
FundShares% Held
AdvisorShares Trust-AdvisorShares Psychedelics ETF400.38K10.49%

Frequently asked questions

Who is the largest shareholder of Quantum Biopharma?

AdvisorShares Investments, LLC is the largest institutional shareholder of QNTM, owning 5.33% of shares outstanding (203.56K shares) as of its latest 13F filing.

What percentage of Quantum Biopharma is owned by institutions?

Institutions own about 12.0% of QNTM shares and 13.1% of the public float.

How much of Quantum Biopharma do insiders own?

Insiders, such as officers and directors, own about 8.40% of QNTM shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related